Skip to main content

Table 1 Comparison of genotype and frequencies of MTNR1B rs10830963 polymorphism between T2DM patients and healthy subjects

From: Evaluation of the effect of MTNR1B rs10830963 gene variant on the therapeutic efficacy of nateglinide in treating type 2 diabetes among Chinese Han patients

Genotypes Healthy subjects (n = 200) T2DM patients (n = 200) P value
MTNR1B rs10830963
 CC 82(41.00%) 70(35.00%)  
 CG 98(49.00%) 90(45.00%)  
 GG 20(10.00%) 40(20.00%) 0.019Δ*
 C 262(65.50%) 230(57.50%)  
 G 138(34.50%) 170(42.50%) 0.020Δ*
  1. The allelic frequencies are indicated in absolute values (percentage). ΔP values are determined by the Pearson chi-square test. *P < 0.05